IPO - Transcode Therapeutics, Inc.

Form Type: CORRESP

Filing Date: 2024-12-13

Corporate Action: Ipo

Type: New

Accession Number: 000110465924128518

Filing Summary: TransCode Therapeutics, Inc. has submitted an acceleration request for the effective date of its registration statement on Form S-1, initially filed on December 6, 2024. The company is requesting that the effective date be moved to December 17, 2024, at 5:15 p.m. Eastern Time, or as soon as practicable thereafter. The request is made under Rule 461 of the Securities Act of 1933. The company acknowledges its responsibilities under the Act and requests oral confirmation from its outside counsel, Goodwin Procter LLP, upon approval of the registration statement.